Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes(Radboud University Nijmegen), María J. Ribal(Hospital Clínic de Barcelona), Y. Neuzillet(Université de Versailles Saint-Quentin-en-Yvelines), Thierry Lebrét(Université de Versailles Saint-Quentin-en-Yvelines), Estefanía Linares(Hospital Universitario La Paz), Erik Veskimäe(Tampere University), Antoine G. van der Heijden(Radboud University Nijmegen), Éva Compérat(Vienna General Hospital), Nigel C. Cowan(Queen Alexandra Hospital), Maria De Santis(Medical University of Vienna), Virginia Hernández(Hospital Universitario Fundación Alcorcón), Georgios Gakis(University Hospital in Halle), Mathieu Rouanne(Université de Versailles Saint-Quentin-en-Yvelines), James Dunn(Stanford University), H.M. Bruins(Radboud University Nijmegen)
Cited by 1,517
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694